Global Molecular Diagnostics and NAT Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Molecular Diagnostics and NAT Revenue
• 1.4 Market by Type
  • 1.4.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Amplification Technologies
  • 1.4.3 Amplified Gene Detection Technologies
  • 1.4.4 DNA And Oligonucleotide Microarrays
  • 1.4.5 Gene Sequencing
• 1.5 Market by Application
  • 1.5.1 Global Molecular Diagnostics and NAT Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and Clinics
  • 1.5.3 Research Institutes
  • 1.5.4 Diagnostic Centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Molecular Diagnostics and NAT Market Perspective (2015-2026)
• 2.2 Global Molecular Diagnostics and NAT Growth Trends by Regions
  • 2.2.1 Molecular Diagnostics and NAT Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Molecular Diagnostics and NAT Historic Market Share by Regions (2015-2020)
  • 2.2.3 Molecular Diagnostics and NAT Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Molecular Diagnostics and NAT Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Molecular Diagnostics and NAT Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Molecular Diagnostics and NAT Players by Market Size
  • 3.1.1 Global Top Molecular Diagnostics and NAT Players by Revenue (2015-2020)
  • 3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Molecular Diagnostics and NAT Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Molecular Diagnostics and NAT Market Concentration Ratio
  • 3.2.1 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics and NAT Revenue in 2019
• 3.3 Molecular Diagnostics and NAT Key Players Head office and Area Served
• 3.4 Key Players Molecular Diagnostics and NAT Product Solution and Service
• 3.5 Date of Enter into Molecular Diagnostics and NAT Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Molecular Diagnostics and NAT Historic Market Size by Type (2015-2020)
• 4.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Molecular Diagnostics and NAT Market Size by Application (2015-2020)
• 5.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Molecular Diagnostics and NAT Market Size (2015-2020)
• 6.2 Molecular Diagnostics and NAT Key Players in North America (2019-2020)
• 6.3 North America Molecular Diagnostics and NAT Market Size by Type (2015-2020)
• 6.4 North America Molecular Diagnostics and NAT Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Molecular Diagnostics and NAT Market Size (2015-2020)
• 7.2 Molecular Diagnostics and NAT Key Players in Europe (2019-2020)
• 7.3 Europe Molecular Diagnostics and NAT Market Size by Type (2015-2020)
• 7.4 Europe Molecular Diagnostics and NAT Market Size by Application (2015-2020)

8 China

• 8.1 China Molecular Diagnostics and NAT Market Size (2015-2020)
• 8.2 Molecular Diagnostics and NAT Key Players in China (2019-2020)
• 8.3 China Molecular Diagnostics and NAT Market Size by Type (2015-2020)
• 8.4 China Molecular Diagnostics and NAT Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Molecular Diagnostics and NAT Market Size (2015-2020)
• 9.2 Molecular Diagnostics and NAT Key Players in Japan (2019-2020)
• 9.3 Japan Molecular Diagnostics and NAT Market Size by Type (2015-2020)
• 9.4 Japan Molecular Diagnostics and NAT Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Molecular Diagnostics and NAT Market Size (2015-2020)
• 10.2 Molecular Diagnostics and NAT Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Molecular Diagnostics and NAT Market Size by Type (2015-2020)
• 10.4 Southeast Asia Molecular Diagnostics and NAT Market Size by Application (2015-2020)

11 India

• 11.1 India Molecular Diagnostics and NAT Market Size (2015-2020)
• 11.2 Molecular Diagnostics and NAT Key Players in India (2019-2020)
• 11.3 India Molecular Diagnostics and NAT Market Size by Type (2015-2020)
• 11.4 India Molecular Diagnostics and NAT Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Molecular Diagnostics and NAT Market Size (2015-2020)
• 12.2 Molecular Diagnostics and NAT Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Molecular Diagnostics and NAT Market Size by Type (2015-2020)
• 12.4 Central & South America Molecular Diagnostics and NAT Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche
  • 13.1.1 Roche Company Details
  • 13.1.2 Roche Business Overview
  • 13.1.3 Roche Molecular Diagnostics and NAT Introduction
  • 13.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2015-2020))
  • 13.1.5 Roche Recent Development
• 13.2 Abbott
  • 13.2.1 Abbott Company Details
  • 13.2.2 Abbott Business Overview
  • 13.2.3 Abbott Molecular Diagnostics and NAT Introduction
  • 13.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.2.5 Abbott Recent Development
• 13.3 BD
  • 13.3.1 BD Company Details
  • 13.3.2 BD Business Overview
  • 13.3.3 BD Molecular Diagnostics and NAT Introduction
  • 13.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.3.5 BD Recent Development
• 13.4 Biomerieux
  • 13.4.1 Biomerieux Company Details
  • 13.4.2 Biomerieux Business Overview
  • 13.4.3 Biomerieux Molecular Diagnostics and NAT Introduction
  • 13.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.4.5 Biomerieux Recent Development
• 13.5 Qiagen
  • 13.5.1 Qiagen Company Details
  • 13.5.2 Qiagen Business Overview
  • 13.5.3 Qiagen Molecular Diagnostics and NAT Introduction
  • 13.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.5.5 Qiagen Recent Development
• 13.6 Thermo Fisher Scientific
  • 13.6.1 Thermo Fisher Scientific Company Details
  • 13.6.2 Thermo Fisher Scientific Business Overview
  • 13.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Introduction
  • 13.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.6.5 Thermo Fisher Scientific Recent Development
• 13.7 Agilent
  • 13.7.1 Agilent Company Details
  • 13.7.2 Agilent Business Overview
  • 13.7.3 Agilent Molecular Diagnostics and NAT Introduction
  • 13.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.7.5 Agilent Recent Development
• 13.8 GenMark
  • 13.8.1 GenMark Company Details
  • 13.8.2 GenMark Business Overview
  • 13.8.3 GenMark Molecular Diagnostics and NAT Introduction
  • 13.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.8.5 GenMark Recent Development
• 13.9 Siemens Healthcare
  • 13.9.1 Siemens Healthcare Company Details
  • 13.9.2 Siemens Healthcare Business Overview
  • 13.9.3 Siemens Healthcare Molecular Diagnostics and NAT Introduction
  • 13.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.9.5 Siemens Healthcare Recent Development
• 13.10 AutoGenomics
  • 13.10.1 AutoGenomics Company Details
  • 13.10.2 AutoGenomics Business Overview
  • 13.10.3 AutoGenomics Molecular Diagnostics and NAT Introduction
  • 13.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2015-2020)
  • 13.10.5 AutoGenomics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer